Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Efficacy and safety of glecaprevir/pibrentasvir in patients with chronic HCV infection and psychiatric disorders: An integrated analysis
David Back, Pamela S. Belperio, Mark Bondin, et al.
Journal of Viral Hepatitis (2019) Vol. 26, Iss. 8, pp. 951-960
Open Access | Times Cited: 25

Showing 25 citing articles:

Natural History of Hepatic and Extrahepatic Hepatitis C Virus Diseases and Impact of Interferon-Free HCV Therapy
Francesco Negro
Cold Spring Harbor Perspectives in Medicine (2019) Vol. 10, Iss. 4, pp. a036921-a036921
Open Access | Times Cited: 26
Safety and Effectiveness Using 8 Weeks of Glecaprevir/Pibrentasvir in HCV-Infected Treatment-Naïve Patients with Compensated Cirrhosis: The CREST Study
Markus Cornberg, Adriana Ahumada, Alessio Aghemo, et al.
Advances in Therapy (2022) Vol. 39, Iss. 7, pp. 3146-3158
Open Access | Times Cited: 14
Real-world effectiveness and safety of direct-acting antivirals in hepatitis C virus patients with mental disorders
Dorota Dybowska, Dorota Zarębska‐Michaluk, Piotr Rzymski, et al.
World Journal of Gastroenterology (2023) Vol. 29, Iss. 25, pp. 4085-4098
Open Access | Times Cited: 7
Patients with severe mental illness and hepatitis C virus infection benefit from new pangenotypic direct-acting antivirals: Results of a literature review
Luís Gutiérrez-Rojas, Jesús José de la Gándara Martín, Luisa García Buey, et al.
Gastroenterología y Hepatología (2022) Vol. 46, Iss. 5, pp. 382-396
Open Access | Times Cited: 12
Effects of Direct-Acting Antiviral Agents on the Mental Health of Patients with Chronic Hepatitis C: A Prospective Observational Study
Michele Fabrazzo, Rosa Zampino, Martina Vitrone, et al.
Brain Sciences (2020) Vol. 10, Iss. 8, pp. 483-483
Open Access | Times Cited: 15
Predictors of hepatitis C treatment outcomes in a harm reduction-focused primary care program in New York City
Jacob Ziff, Trang Vu, Danielle Dvir, et al.
Harm Reduction Journal (2021) Vol. 18, Iss. 1
Open Access | Times Cited: 14
Efficacy and tolerability of DAAs in HCV-monoinfected and HCV/HIV-coinfected patients with psychiatric disorders
Nicolò De Gennaro, Lucia Diella, Laura Monno, et al.
BMC Infectious Diseases (2020) Vol. 20, Iss. 1
Open Access | Times Cited: 13
Efficacy and Safety of Glecaprevir/Pibrentasvir in Patients with Chronic HCV Infection
Xiaoqing Liu, Peng Hu
Journal of Clinical and Translational Hepatology (2021) Vol. 000, Iss. 000, pp. 000-000
Open Access | Times Cited: 12
Depression and anxiety management in cirrhosis
Paula C. Zimbrean, Simona Jakab
Hepatology Communications (2024) Vol. 9, Iss. 1
Open Access | Times Cited: 1
Treating the Hardest to Treat: Reframing the Hospital Admission as an Opportunity to Initiate Hepatitis C Treatment
Elizabeth Le, Grace M. Chee, Miki Kwan, et al.
Digestive Diseases and Sciences (2021) Vol. 67, Iss. 4, pp. 1244-1251
Closed Access | Times Cited: 8
Effects of Direct-Acting Antiviral Agents on the Mental Health of Patients with Chronic Hepatitis C: A Prospective Observational Study
Michele Fabrazzo, Rosa Zampino, Martina Vitrone, et al.
(2020)
Open Access | Times Cited: 6
Patients with severe mental illness and hepatitis C virus infection benefit from new pangenotypic direct-acting antivirals: Results of a literature review
Luís Gutiérrez-Rojas, Jesús José de la Gándara Martín, Luisa García Buey, et al.
Gastroenterología y Hepatología (English Edition) (2023) Vol. 46, Iss. 5, pp. 382-396
Open Access | Times Cited: 2
Relationship between depressive symptoms and adherence to direct-acting antivirals: Implications for Hepatitis C treatment among people who inject drugs on medications for opioid use disorder
Irene Pericot‐Valverde, Moonseong Heo, Jiajing Niu, et al.
Drug and Alcohol Dependence (2022) Vol. 234, pp. 109403-109403
Open Access | Times Cited: 4
Overreporting of adherence to hepatitis C direct-acting antiviral therapy and sustained virologic response among people who inject drugs in the HERO study
Snehal Lopes, Irene Pericot‐Valverde, Paula J. Lum, et al.
BMC Infectious Diseases (2024) Vol. 24, Iss. 1
Open Access
Low risk of viral hepatitis amongst patients with severe mental disorders
Tabatha Fernández‐Plaza, Teresa Plana, Laia Tardón, et al.
Liver International (2023) Vol. 43, Iss. 6, pp. 1204-1212
Open Access | Times Cited: 1
Characteristics associated with receipt of treatment among patients diagnosed with chronic hepatitis C virus
Stuart C. Gordon, Ankita Kaushik, Benjamin Chastek, et al.
Journal of Viral Hepatitis (2023) Vol. 30, Iss. 9, pp. 756-764
Open Access | Times Cited: 1
Direct‑acting antiviral treatment is safe and effective for chronic HCV patients with psychiatric disorders
Hiroshi Okano, Takanori Takenaka, Hiroki Asakawa, et al.
Experimental and Therapeutic Medicine (2023) Vol. 26, Iss. 2
Open Access | Times Cited: 1
Effectiveness and safety of direct‐acting antivirals in hepatitis C infected patients with mental disorders: Results in real clinical practice
Luis Margusino‐Framiñán, Eva Bobadilla‐Pérez, Purificación Cid‐Silva, et al.
Journal of Medical Virology (2020) Vol. 92, Iss. 12, pp. 3488-3498
Open Access | Times Cited: 2
Ombitasvir/paritaprevir/ritonavir and dasabuvir±ribavirin for chronic HCV infection in US veterans with psychiatric disorders
Michael Fuchs, Alexander Monto, Norbert Bräu, et al.
Journal of Medical Virology (2019) Vol. 92, Iss. 12, pp. 3459-3464
Open Access | Times Cited: 1
Glecaprevir-pibrentasvir for chronic hepatitis C – a clinical review
Alireza Fakhri Ravari, Minh Hien Chau Nguyen, Roberto Clemente Garcia
Gastroenterology & Hepatology Open Access (2022) Vol. 12, Iss. 5, pp. 135-150
Open Access | Times Cited: 1
Hepatitis C virus in people with serious mental illness: an analysis of the care cascade at a tertiary health service with a pilot ‘identify and treat’ strategy
Michael Braude, Timothy S. Phan, Danny Con, et al.
Internal Medicine Journal (2021) Vol. 53, Iss. 5, pp. 700-708
Closed Access | Times Cited: 1
Efficacy and tolerability of DAAs in HCV-monoinfected and HCV/HIV-coinfected patients with psychiatric disorders
Nicolò De Gennaro, Lucia Diella, Laura Monno, et al.
Research Square (Research Square) (2020)
Open Access
Efficacy and tolerability of DAAs in HCV-monoinfected and HCV/HIV-coinfected patients with psychiatric disorders
Nicolò De Gennaro, Lucia Diella, Laura Monno, et al.
Research Square (Research Square) (2020)
Open Access
Deleted Work

(1955)
Closed Access
Page 1

Scroll to top